Why the study?
Does the HeartMate 3 LVAD improve survival and reduce complications compared to the HeartWare LVAD?
Does the HeartMate 3 LVAD improve survival and reduce complications compared to the HeartWare LVAD?
Answers are grounded in this paper and cite their sources.
HeartMate 3 LVADs demonstrate superior survival and lower complication rates compared to HeartWare devices at 2 years post-implantation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Numan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: